H
H Santander
Publications - 1
Citations - 149
H Santander is an academic researcher. The author has contributed to research in topics: Prednisolone & Pemphigoid. The author has an hindex of 1, co-authored 1 publications receiving 109 citations.
Papers
More filters
Journal ArticleDOI
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
Hywel C Williams,Fenella Wojnarowska,Gudula Kirtschig,Gudula Kirtschig,James Mason,Thomas R. Godec,Enno Schmidt,Joanne R Chalmers,Margaret Childs,S. Walton,Karen E. Harman,A. Chapman,Diane Whitham,Andrew J. Nunn,J Adams,V Akhras,Alexander Vincent Anstey,C Barnard,H K Bell,S Blackford,Eva-B. Bröcker,A Carmichael,R.R. Coelho,Fiona Craig,K Davies,Robert Ellis,John C. English,Regine Gläser,Richard Groves,C Günthert,P J Hampton,N. Hepburn,Rainer Hügel,K. Hussain,John R. Ingram,Alison M Layton,Nick J. Levell,V Lewis,H Malhomme,A Omerod,Girish Khandubhai Patel,R Rallan,Jane Ravenscroft,H Santander,Kerstin Steinbrink,Michael Sticherling,C Thomas,M Vatve,N. van Beek,V Venning,Emma Veysey,R. Wachsmuth,Shyamal Wahie,B Walker,M Walsh,J Wee,M Westmoreland,G Wong,Adam Ferguson,Indre Verpetinske,Emilia Duarte-Williamson,Fiona Antony,Chris Bower,David Gawkrodger,Kathy Taghipour,M G S Dunnill,Alex Waters,Walter Bottomley,Andrew M Wright,Jane C. Sterling,Adzura Azam,Sam Gibbs,Thomas A. Luger,Ingrid Salvary,Chris Lovell,Andrew Ilchyshyn,Karen Gibbon,Marinella Nik,Robert Charles-Holmes,A Lloyd Lavery +79 more
TL;DR: Starting patients on doxycycline is non-inferior to standard treatment with oral prednisolone for short-term blister control in bullous pemphigoid and significantly safer in the long-term.